Stock listing
OTC:OILAF Optiscan Imaging Limited Stock
US listing (OTC) of Optiscan Imaging Limited · home listing ASX:OIL
Follow Optiscan Imaging Limited into a list and get an email when it puts out news.
Home listing price · ASX:OIL
$0.12 AUD -0.02 (-14.3%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, ASX:OIL
- Day range
- $0.10 – $0.125 AUDNov 20, 2026
- Volume
- 862,098 sharesNov 20, 2026
- Market cap
- $125.5M AUDAt the close on Nov 20, 2026 · price × 1.05B shares outstanding
- 52-week range
- $0.08 – $0.20 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $27,885 AUDMedian day 119,167 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:OIL · Home | $0.12 AUD | -0.02 (-14.3%) | 862,098 | $0.125 | $0.125 | $0.10 | $0.14 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:OIL · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.12 | -0.02 | -14.3% | $0.125 | $0.125 | $0.10 | 862,098 | |
| $0.14 | -0.005 | -3.4% | $0.15 | $0.15 | $0.135 | 307,822 | |
| $0.145 | -0.01 | -6.5% | $0.15 | $0.155 | $0.145 | 55,086 | |
| $0.155 | 0.00 | 0.0% | $0.155 | $0.155 | $0.145 | 90,549 | |
| $0.155 | -0.003 | -1.6% | $0.155 | $0.16 | $0.155 | 43,104 | |
| $0.158 | +0.003 | +1.6% | $0.155 | $0.16 | $0.155 | 45,649 | |
| $0.155 | -0.005 | -3.1% | $0.155 | $0.155 | $0.155 | 506 | |
| $0.16 | 0.00 | 0.0% | $0.16 | $0.165 | $0.155 | 123,300 | |
| $0.16 | -0.005 | -3.0% | $0.16 | $0.17 | $0.155 | 325,639 | |
| $0.165 | +0.01 | +6.5% | $0.155 | $0.17 | $0.155 | 199,549 | |
| $0.155 | +0.005 | +3.3% | $0.16 | $0.16 | $0.155 | 44,066 | |
| $0.15 | -0.01 | -6.3% | $0.155 | $0.16 | $0.15 | 81,181 | |
| $0.16 | +0.01 | +6.7% | $0.153 | $0.16 | $0.15 | 119,167 | |
| $0.15 | -0.005 | -3.2% | $0.15 | $0.15 | $0.14 | 163,167 | |
| $0.155 | +0.005 | +3.3% | $0.15 | $0.155 | $0.145 | 200,756 | |
| $0.15 | +0.005 | +3.4% | $0.155 | $0.16 | $0.15 | 46,395 | |
| $0.145 | +0.005 | +3.6% | $0.14 | $0.145 | $0.14 | 22,023 | |
| $0.14 | -0.015 | -9.7% | $0.16 | $0.16 | $0.14 | 57,321 | |
| $0.155 | -0.005 | -3.1% | $0.155 | $0.16 | $0.153 | 209,042 | |
| $0.16 | +0.005 | +3.2% | $0.16 | $0.165 | $0.16 | 59,261 | |
| $0.155 | 0.00 | 0.0% | $0.165 | $0.17 | $0.155 | 60,350 | |
| $0.155 | 0.00 | 0.0% | $0.155 | $0.16 | $0.15 | 47,973 | |
| $0.155 | 0.00 | 0.0% | $0.16 | $0.16 | $0.155 | 10,815 | |
| $0.155 | -0.01 | -6.1% | $0.165 | $0.165 | $0.155 | 176,746 | |
| $0.165 | +0.025 | +17.9% | $0.145 | $0.165 | $0.145 | 711,876 | |
| $0.14 | -0.015 | -9.7% | $0.155 | $0.16 | $0.14 | 369,608 | |
| $0.155 | -0.005 | -3.1% | $0.16 | $0.16 | $0.145 | 106,948 | |
| $0.16 | -0.005 | -3.0% | $0.17 | $0.175 | $0.15 | 650,244 | |
| $0.165 | +0.005 | +3.1% | $0.16 | $0.17 | $0.16 | 225,223 | |
| $0.16 | -0.015 | -8.6% | $0.17 | $0.17 | $0.155 | 220,746 | |
| $0.175 | -0.005 | -2.8% | $0.17 | $0.18 | $0.17 | 152,245 | |
| $0.18 | 0.00 | 0.0% | $0.18 | $0.185 | $0.17 | 317,813 | |
| $0.18 | +0.01 | +5.9% | $0.177 | $0.195 | $0.177 | 346,461 | |
| $0.17 | +0.005 | +3.0% | $0.17 | $0.195 | $0.17 | 439,779 | |
| $0.165 | +0.005 | +3.1% | $0.16 | $0.17 | $0.16 | 341,322 | |
| $0.16 | +0.025 | +18.5% | $0.135 | $0.16 | $0.13 | 575,151 | |
| $0.135 | 0.00 | 0.0% | $0.13 | $0.135 | $0.13 | 58,876 | |
| $0.135 | 0.00 | 0.0% | $0.137 | $0.14 | $0.13 | 119,543 | |
| $0.135 | +0.005 | +3.8% | $0.135 | $0.14 | $0.13 | 168,759 | |
| $0.13 | -0.01 | -7.1% | $0.14 | $0.14 | $0.13 | 78,099 | |
| $0.14 | +0.005 | +3.7% | $0.135 | $0.14 | $0.135 | 29,799 | |
| $0.135 | -0.005 | -3.6% | $0.145 | $0.145 | $0.135 | 20,385 | |
| $0.14 | 0.00 | 0.0% | $0.14 | $0.145 | $0.14 | 44,135 | |
| $0.14 | -0.01 | -6.7% | $0.15 | $0.15 | $0.14 | 71,693 | |
| $0.15 | +0.005 | +3.4% | $0.145 | $0.15 | $0.14 | 13,897 | |
| $0.145 | 0.00 | 0.0% | $0.145 | $0.155 | $0.14 | 40,342 | |
| $0.145 | -0.015 | -9.4% | $0.15 | $0.15 | $0.14 | 18,536 | |
| $0.16 | +0.01 | +6.7% | $0.16 | $0.16 | $0.14 | 141,745 | |
| $0.15 | -0.005 | -3.2% | $0.155 | $0.155 | $0.135 | 463,843 | |
| $0.155 | +0.005 | +3.3% | $0.15 | $0.165 | $0.15 | 61,808 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.145 | 5,854 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.16 | $0.14 | 376,399 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.155 | $0.15 | 33,955 | |
| $0.15 | +0.005 | +3.4% | $0.145 | $0.155 | $0.145 | 23,793 | |
| $0.145 | -0.015 | -9.4% | $0.16 | $0.16 | $0.145 | 49,008 | |
| $0.16 | +0.01 | +6.7% | $0.15 | $0.16 | $0.135 | 475,659 | |
| $0.15 | -0.005 | -3.2% | $0.155 | $0.155 | $0.145 | 56,275 | |
| $0.155 | 0.00 | 0.0% | $0.155 | $0.155 | $0.14 | 353,846 | |
| $0.155 | 0.00 | 0.0% | $0.16 | $0.16 | $0.15 | 153,510 | |
| $0.155 | -0.01 | -6.1% | $0.165 | $0.165 | $0.15 | 311,958 | |
| $0.165 | 0.00 | 0.0% | $0.165 | $0.167 | $0.16 | 121,374 | |
| $0.165 | -0.01 | -5.7% | $0.17 | $0.18 | $0.165 | 123,297 | |
| $0.175 | +0.005 | +2.9% | $0.17 | $0.175 | $0.165 | 359,221 | |
| $0.17 | 0.00 | 0.0% | $0.17 | $0.17 | $0.165 | 7,039 | |
| $0.17 | +0.01 | +6.3% | $0.16 | $0.17 | $0.15 | 72,524 |
Splits
1 split · ASX:OIL · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 99-for-97 | Split |
- Ticker
- OTC:OILAF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Extension of Time to Hold Annual General Meeting
Latest deck · Nov 17, 2026
Bell Potter Healthcare Conference (November 2026)
Conference · 11 slides
Latest news
Extension of Time to Hold Annual General Meeting
Nov 19, 2026
Closed $0.12 (-14.3%) on Nov 20, 2026
Bell Potter Healthcare Conference Presentation
Nov 16, 2026
Closed $0.145 (-6.5%) on Nov 17, 2026
Optiscan Strengthens Board with Appointment of Russell Low
Nov 4, 2026
Closed $0.155 (+3.3%) on Nov 5, 2026
Notification of cessation of securities - OIL
Nov 3, 2026
Closed $0.15 (-6.3%) on Nov 4, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
Oct 29, 2026
Closed $0.155 (+3.3%) on Oct 30, 2026
Optiscan Lodges U.S. FDA 510(k) Submission for InVue
Oct 4, 2026
Closed $0.17 (+3.0%) on Oct 5, 2026
Optiscan Lodges U.S. FDA 510(k) Submission for InForm
Oct 1, 2026
Closed $0.16 (+18.5%) on Oct 1, 2026
Change of Director's Interest Notice
Sep 15, 2026
Closed $0.145 (0.0%) on Sep 16, 2026
Application for quotation of securities - OIL
Sep 15, 2026
Closed $0.145 (0.0%) on Sep 16, 2026
Significant Milestone Reached in ACL Digital Pathology Study
Sep 9, 2026
Closed $0.155 (+3.3%) on Sep 10, 2026
Optiscan Imaging Limited on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 32 in the last 12 months · 198 in all · newest Nov 19, 2026 · oldest 2016
- Decks
- 38 decks · latest Nov 17, 2026
Where Optiscan Imaging Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:OIL · Home listing | ASX | Australia | AUD |
| OTC:OILAF · This page | OTC | United States | USD |
Valuation
EV/sales 251× against a median of 1.8×: the highest of 9 Medical devices & supplies companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $112.5M AUD
- P/E
- Loss
- EV/sales
- 251×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 6.6×
- Gross margin
- −176.1%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Optiscan Imaging Limited · ASX:OIL | US$83.05M | US$74.44M | n/a | 251× | n/a | 6.6× | n/a | 0.1× | n/a |
| SciVision Biotech Inc. · TWSE:1786 | US$88.98M | US$76.24M | 16.5× | 2.8× | 10.7× | 1.6× | 20.0% | 0.3× | n/a |
| Owlet, Inc. · NYSE:OWLT | US$87.58M | US$66.96M | n/a | 0.6× | n/a | 3.3× | −10.2% | 0.4× | 2.11 |
| EMvision Medical Devices Ltd. · ASX:EMV | US$87.37M | US$78.30M | n/a | n/a | n/a | 8.4× | n/a | 0.2× | n/a |
| Maxigen Biotech Inc. · TWSE:1783 | US$86.53M | US$59.38M | 9.8× | 2.3× | 6.7× | 1.9× | 34.8% | 0.1× | n/a |
| Viromed Medical AG · XETR:VME | US$83.96M | US$83.66M | 127× | 15.0× | n/a | 8.1× | 11.9% | 0.0× | n/a |
| ICARES Medicus Inc · TPEX:6612 | US$83.86M | US$61.27M | 29.6× | 1.7× | 7.3× | 1.5× | 7.7% | 0.0× | n/a |
| Nyxoah SA · EURONEXT:NYXH | US$83.60M | US$6.53M | n/a | 0.3× | n/a | 0.9× | −443.2% | 0.3× | n/a |
| EBR Systems, Inc. · ASX:EBR | US$79.78M | US$36.17M | n/a | n/a | n/a | 1.0× | n/a | 0.5× | n/a |
| DIO Corporation · KRX:039840 | US$78.78M | US$59.85M | 4.8× | 0.5× | 3.4× | 0.6× | 12.7% | 0.1× | n/a |
| Zomedica Corp. · OTC:ZOMDF | US$78.49M | US$71.21M | n/a | 1.8× | n/a | 0.8× | −41.3% | 0.0× | 0.10 |
| Median of the others | US$83.91M | US$64.12M | 16.5× | 1.8× | 7.0× | 1.6× | 9.8% | 0.2× | 1.11 |
Team and board
Officers
| Officer | Role |
|---|---|
| Camile Farah | Chief Executive Officer |
| Darius Ooi | Chief Financial Officer |
| Elissa Hansen | Company Secretary |
| Jessica Ward | Director of Clinical and Regulatory Affairs |
| Robert Sayegh | Director of Strategy & Portfolio Integration |
| Sanchitha Fernando | Chief Technology Officer |
Board
| Director | Role |
|---|---|
| Robert Cooke | Non-Executive Chairman |
| Karen Borg | Non-Executive Director |
| Ron Song | Non-Executive Director |
| Russell Low | Non-Executive Director |
| Sean Gardiner | Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Aug 29, 2025 | |
| Q2 2025 | Feb 27, 2025 | 0.0% |
| Q2 2023 | Feb 27, 2023 · After close | −4.1% |
| Q4 2022 | Aug 31, 2022 · After close | 0.0% |
| Q2 2022 | Feb 24, 2022 | +12.5% |
| Q4 2021 | Aug 29, 2021 | 0.0% |
| Q2 2021 | Feb 25, 2021 | +6.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Bell Potter Healthcare Conference (November 2026) | Conference | 11 slides | Nov 17, 2026 |
| Investor Presentation (December 2025) | Investor deck | 37 slides | Dec 4, 2025 |
| Shareholder Meeting (November 2025) | Shareholder meeting | 40 slides | Nov 14, 2025 |
| ASX SMIDcaps Conference, Sydney 2025 | Conference | 22 slides | Sep 24, 2025 |
| Corporate Update (April 2025) | Corporate update | 26 slides | Apr 10, 2025 |
| TSN ASX Gems Conference (March 2025) | Conference | 16 slides | Mar 28, 2025 |
| Shareholder Meeting (November 2024) | Shareholder meeting | 26 slides | Nov 21, 2024 |
| Non-Deal Roadshow (July 2024) | Roadshow | 29 slides | Jul 1, 2024 |
| Investor Presentation (May 2024) | Investor deck | 25 slides | May 16, 2024 |
| Shareholder Meeting (November 2023) | Shareholder meeting | 34 slides | Nov 23, 2023 |
All 38 decks
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 448.8K | 3.72M | 1.16M | 1.68M | 1.01M | 889.5K | 1.19M | 1.32M | 2.97M | 1.33M |
| Cost of revenue | 1.24M | 472.1K | 526.2K | 1.17M | 2.67M | 1.28M | 640.6K | 1.11M | 1.25M | 506.5K |
| Gross profit | -790.2K | 3.25M | 629.4K | 514.8K | -1.66M | -385.9K | 550.1K | 216.3K | 1.72M | 826.8K |
| Research and development | 6.28M | 5.09M | 3.90M | 2.44M | 2.17M | 1.67M | 1.61M | 703.8K | 1.97M | 2.21M |
| Selling, general and administrative | 4.18M | 4.17M | 4.35M | 3.60M | 1.65M | 1.24M | 984.0K | 1.16M | 1.63M | 1.50M |
| Operating income | -10.6M | -6.17M | -8.41M | -5.29M | -5.47M | -3.72M | -2.38M | -2.35M | -2.00M | -3.88M |
| Depreciation and amortization | 322.7K | 429.6K | 567.3K | 378.8K | 240.6K | 238.3K | 237.2K | 122.1K | 88.6K | 41.8K |
| EBITDA | -10.3M | -5.74M | -7.85M | -4.91M | -5.23M | -3.48M | -2.15M | -2.23M | -1.92M | -3.84M |
| Interest expense | 81.5K | 25.8K | 23.7K | 32.3K | 32.2K | 56.3K | 63.9K | 63.9K | 42.5K | 72.5K |
| Income before tax | -9.37M | -6.29M | -6.06M | -5.09M | -5.17M | -2.97M | -2.47M | -2.34M | -2.04M | -2.94M |
| Income tax | -2.39M | 20.3K | -994.7K | -737.6K | -941.8K | -847.3K | -701.2K | -230.9K | -781.8K | -980.3K |
| Net income | -6.99M | -6.31M | -6.06M | -4.35M | -4.23M | -2.13M | -1.77M | -2.34M | -2.04M | -2.94M |
| Earnings per share, basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.01 | -0.00 | -0.01 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 14.4M | 4.55M | 6.10M | 875.4K | 4.53M | 8.44M | 526.4K | 1.75M | 1.56M | 700.7K |
| Short-term investments | 5.13M | 53.6K | 53.6K | 0 | ||||||
| Receivables | 2.85M | 316.6K | 1.57M | 975.9K | 1.41M | 1.24M | 758.4K | 150.3K | 346.5K | 230.4K |
| Inventory | 2.35M | 1.67M | 2.00M | 1.44M | 1.27M | 1.16M | 1.15M | 1.16M | 885.6K | 495.9K |
| Current assets | 20.4M | 8.86M | 15.1M | 3.65M | 7.32M | 11.0M | 2.51M | 3.36M | 3.72M | 2.51M |
| Property, plant and equipment | 1.69M | 407.3K | 575.7K | 609.0K | 675.2K | 882.6K | 227.9K | 345.4K | 159.1K | |
| Total assets | 22.0M | 10.6M | 15.6M | 4.67M | 7.98M | 11.7M | 3.44M | 3.64M | 4.13M | 2.67M |
| Accounts payable | 682.5K | 373.6K | 539.9K | 524.5K | 303.2K | 396.6K | 336.8K | 224.4K | 326.7K | 566.8K |
| Current liabilities | 1.88M | 1.51M | 1.75M | 1.42M | 1.00M | 973.4K | 1.24M | 818.4K | 915.2K | 994.8K |
| Total debt | 1.34M | 1.48M | 220.9K | 412.3K | 570.9K | 668.0K | 1.16M | 200.0K | ||
| Total liabilities | 3.08M | 2.84M | 1.76M | 1.63M | 1.39M | 1.48M | 1.90M | 820.6K | 928.7K | 1.00M |
| Shareholders' equity | 18.9M | 7.71M | 13.9M | 3.04M | 6.59M | 10.2M | 1.55M | 2.82M | 3.20M | 1.67M |
| Shares outstanding | 996.1M | 835.3M | 822.9M | 623.3M | 631.1M | 583.2M | 484.1M | 442.6M | 414.9M | 333.5M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -7.10M | -6.21M | -5.74M | -3.15M | -3.83M | -2.13M | -1.40M | -1.42M | -2.32M | -3.41M |
| Capital spending | -256.0K | -93.1K | -87.4K | -126.9K | -124.1K | -30.9K | -20.2K | -4.51K | -290.5K | -181.2K |
| Free cash flow | -7.36M | -6.31M | -5.83M | -3.28M | -3.96M | -2.16M | -1.42M | -1.43M | -2.61M | -3.59M |
| Cash from investing | -256.0K | 5.05M | -5.23M | -126.9K | -124.1K | -30.9K | -20.2K | 5.49K | -353.1K | -181.2K |
| Cash from financing | 17.2M | -381.9K | 16.2M | -374.5K | 44.6K | 10.1M | 190.7K | 1.61M | 3.54M | 3.34M |
| Dividends paid | -155.6K | -9.82M | -351.5K | -3.02M | ||||||
| Share buybacks | -179.8K | 0 | -104.5K | 41.0K | -200.2K | -423.3K | -4.03K | -94.8K | -298.7K | -289.9K |
| Change in cash | 9.80M | -1.55M | 5.23M | -3.65M | -3.91M | 7.92M | -1.23M | 189.9K | 861.8K | -254.1K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Extension of Time to Hold Annual General Meeting | Nov 19, 2026 | Meeting notice | ASX |
| Bell Potter Healthcare Conference Presentation | Nov 16, 2026 | Operations update | ASX |
| Optiscan Strengthens Board with Appointment of Russell Low | Nov 4, 2026 | Management or board change | ASX |
| Notification of cessation of securities - OIL | Nov 3, 2026 | Financing | ASX |
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 29, 2026 | Quarterly report | ASX |
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 29, 2026 | Quarterly report | ASX |
| Optiscan Lodges U.S. FDA 510(k) Submission for InVue | Oct 4, 2026 | Operations update | ASX |
| Optiscan Lodges U.S. FDA 510(k) Submission for InForm | Oct 1, 2026 | Operations update | ASX |
| Change of Director's Interest Notice | Sep 15, 2026 | Ownership change notice | ASX |
| Notification of cessation of securities - OIL | Sep 15, 2026 | Financing | ASX |
All 194 filings
Cap table
Built by 6ix from Optiscan Imaging Limited’s releases
- Common shares
- 1,045,612,380
- Fully diluted
- 1,045,612,380
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 1,045,612,380 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 1,045,612,380 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Camile Farah | Chief Executive Officer · Since at least Nov 5, 2026 |
| Darius Ooi | Chief Financial Officer · Since at least Nov 4, 2026 |
| Elissa Hansen | Company Secretary · Since at least Nov 5, 2026 |
| Hiran Jayetileke | Manufacturing Manager · Nov 4, 2026 – Nov 7, 2026 · Past |
| Jessica Ward | Director of Clinical and Regulatory Affairs · Since at least Nov 4, 2026 |
| Karen Borg | Non-Executive Director · Since at least Nov 5, 2026 |
| Kaylene Dawson | General Counsel · Nov 4, 2026 – Nov 7, 2026 · Past |
| Lindsay Bussau | Applications & Customer Support Manager · Nov 4, 2026 – Nov 7, 2026 · Past |
| Paul Unwin | Supply Chain, Service and Infrastructure Manager · Nov 4, 2026 – Nov 7, 2026 · Past |
| Peter Pavlicek | Project Manager · Nov 4, 2026 – Nov 7, 2026 · Past |
All 17 people
| Person | Seat |
|---|---|
| Robert Cooke | Non-Executive Chairman · Since at least Nov 5, 2026 |
| Robert Sayegh | Director of Strategy & Portfolio Integration · Since at least Nov 7, 2026 |
| Ron Song | Non-Executive Director · Since at least Nov 5, 2026 |
| Russell Low | Non-Executive Director · Since at least Nov 5, 2026 |
| Sanchitha Fernando | Chief Technology Officer · Since at least Nov 4, 2026 |
| Sean Gardiner | Non-Executive Director · Since at least Nov 5, 2026 |
| Yameena Cossins | Quality Assurance Manager · Nov 4, 2026 – Nov 7, 2026 · Past |
Log in to ask 6ix AI your own questions about Optiscan Imaging Limited.